When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

The effects last only for a few hours. Examples include exenatide and lixisenatide. Ozempic: Novo Nordisk’s name-brand ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Better known by Novo Nordisk's brand names Ozempic and Wegovy (the former of which is indicated only for type 2 diabetes), ...

On a call with investors last week, Danish drugmaker Novo Nordisk shared some teasers about CagriSema, the next generation of ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

Denmark is at the forefront of integrating artificial intelligence within structured regulation, recently launching a new AI ...

The agency is also evaluating Novo Nordisk’s (NVO) semaglutide drugs for the same label ... For example, a starter dose of ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...